In preclinical models of GBA1-linked Parkinson’s disease, a genetic subset accounting for up to 15 percent of cases of the ...

Four out of five trainee doctors have left their training hospitals, but the remaining senior doctors are now considering how ...

SK plasma has signed a joint development and licensing agreement with antibody-drug conjugate (ADC) specialist AIMEDBIO to co ...

The growth engine of Korea's medical device industry has stalled. As of 2024, production fell by 1.7 percent year-on-year.

CHICAGO, Ill. – By Hong Sook / Korea Biomedical Review correspondent -- Pin Therapeutics has set about to target rare cancers ...

Bristol Myers Squibb has won Korean approval for Augtyro (repotrectinib), expanding its reach in targeted lung and solid ...

HLB’s VEGFR inhibitor rivoceranib is drawing renewed attention following a trio of phase 2 data readouts presented at the ...

As the world’s largest biotechnology convention, BIO USA 2025, prepares to open in Boston from June 16 to 19, over 80 Korean ...

Starting this October, medical benefit recipients will be subject to a 30 percent co-payment if their annual outpatient ...

CHICAGO, Ill. - By Kim Yun-mi/ Korea Biomedical Review correspondent --HER2-positive metastatic breast cancer patients with ...

A new study has shown that Ferring Pharmaceuticals Korea's Rekovelle (follitropin delta) is more effective than the ...

Seoul National University Hospital (SNUH) said Thursday that its Department of Clinical Genomic Medicine has signed a ...